Work

Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity

Year: 2022

Type: article

Study design: Observational Study

Source: The American Journal of Medicine

DOI: 10.1016/j.amjmed.2022.08.010

Authors: Mayra Tisminetzky, Jerry H. Gurwitz, Grace Tabada, Kristi Reynolds, Stephen P. Fortmann, Elisha Garcia, Thu Pham, Robert Goldberg, Alan S. Go

Institutions: University of Massachusetts Chan Medical School, Kaiser Permanente, Kaiser Permanente Northern California, Kaiser Permanente Bernard J. Tyson School of Medicine, Kaiser Permanente Center for Health Research, University of California, San Francisco, Stanford Medicine, Stanford University

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute

Awards: TRACE-CORE, Worcester Heart Attack Study, Multimorbidity and Treatment-Related Outcomes in Older Heart Failure Patients, Advancing Geriatrics Infrastructure and Network Growth (AGING) Initiative

OpenAlex ID: W4294169488

FWCI: 0.175

Cites: 41

Cited by: 1

Related to: 10